Drug Topics

MARCH 27, 2024

Two posters presented at APhA 2024 examined how the COVID-19 pandemic impacted pharmacists and their work.

212

212

Drug Topics

JULY 1, 2024

Research presented at the American Diabetes Association 84th Scientific Sessions suggests a population approach to CGM use could be beneficial.

212

212

Pharmacy Times

DECEMBER 18, 2024

Panelists discuss how primary biliary cholangitis (PBC) often presents asymptomatically but can be diagnosed through elevated alkaline phosphatase levels, positive antimitochondrial antibodies, and liver biopsy when necessary.

65

65

Pharmacy Times

AUGUST 9, 2024

A variety of signs and symptoms of lymphoma were reported, including fever, stomach discomfort, and weight loss.

132

132

Drug Topics

MARCH 25, 2024

Researchers presented their findings on hypersensitivity caused by antibiotics as well as the best ways pharmacists can test for it.

210

210

Drug Topics

OCTOBER 8, 2024

Research presented at CHEST 2024 outlined the heart failure risks associated with COVID-19 infection and emphasized the importance of vaccination to prevent adverse outcomes.

Vaccines 211

Vaccines 211

Drug Topics

OCTOBER 16, 2024

Posters presented at ACCP 2024 revealed gaps in pharmacy students’ understanding of off-label drug applications and identified strengths and weaknesses among pharmacy graduates.

Labelling 209

Labelling 209

pharmaphorum

APRIL 17, 2024

Discover how AI is transforming medical communications and reshaping the future of healthcare. Learn about the latest trends, technologies, and advancements in this rapidly evolving field.

Communication 124

Communication 124

Drug Topics

JUNE 14, 2024

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

211

211

Drug Topics

APRIL 5, 2024

In 4 posters presented at the Hematology/Oncology Pharmacy Association Annual Conference 2024, researchers addressed pharmacists’ role in managing patients’ anticancer medications.

Patient Care 199

Patient Care 199

Drug Topics

JANUARY 29, 2024

Three posters being presented at the Society for Maternal-Fetal Medicine 44th Annual Pregnancy Meeting examined the impact of continuous glucose monitoring on pregnancy outcomes.

201

201

Drug Topics

JUNE 26, 2024

At ADA 2024, researchers presented findings from 4 studies that investigated the impact of various new diabetes technologies on managing the condition.

198

198

Drug Topics

MARCH 26, 2024

In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers addressed continuous glucose monitoring and its potential role in indigent communities.

200

200

Pharmacy Times

MAY 29, 2024

Although questions remain about ideal treatment strategies, consistent data have shown that patients should be treated early.

132

132

Drug Topics

MAY 21, 2024

Research presented at Digestive Disease Week suggests that including omega-3 rich foods, or omega-3 supplements, into a healthy diet could offer additional protection against colorectal cancer alongside regular screening.

40

40

Drug Topics

DECEMBER 7, 2023

Two posters presented at ASHP 2023 Midyear examined how accurate answers were from the artificial intelligence chatbot.

211

211

Drug Topics

MARCH 26, 2024

Posters presented at the APhA 2024 Annual Meeting and Exposition discussed pharmacist barriers in pediatric immunizations, a novel meningococcal vaccine, and the need for inpatient reviews of vaccination history.

Vaccines 199

Vaccines Immunization 199

Drug Topics

MARCH 22, 2024

Results from a meta-analysis on the side of effects of the psychedelic psilocybin were presented at the 2024 American Pharmacists Association Annual Meeting & Exposition.

197

197

Drug Topics

OCTOBER 31, 2024

Presenters at the National Community Pharmacists Association 2024 Annual Convention and Expo discussed workflow and the future of pharmacy as a patient destination.

193

193

Drug Topics

NOVEMBER 9, 2024

Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.

187

187

Drug Topics

DECEMBER 13, 2023

Results of the phase 3 PERSEUS study were presented at the 2023 ASH Annual Meeting and Exposition.

200

200

Drug Topics

DECEMBER 4, 2023

An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.

FDA 211

FDA 211

Drug Topics

OCTOBER 23, 2024

New research presented at AMCP Nexus 2024 highlighted the effectiveness and cost-effectiveness of various migraine treatments, including onabotulinumtoxinA and fremanezumab, as well as the importance of migraine education programs for improving patient outcomes.

189

189

Drug Topics

DECEMBER 18, 2023

Three posters presented at the 65th American Society of Hematology Annual Meeting and Exposition looked into the efficacy and safety of the therapies.

201

201

Drug Topics

APRIL 10, 2024

Christopher Bunick, MD, PhD, FAAD, an associate professor of dermatology and a physician-scientist at the Yale School of Medicine in New Haven, Connecticut, presented updates on benzene in BPO at the 2024 American Academy of Dermatology Annual Meeting.

187

187

PhRMA

MAY 11, 2023

Mental Health Awareness Month, which is held each year in May, presents an opportunity to discuss ways to address the growing burden of, and stigma surrounding, mental illness.

213

213

Drug Topics

NOVEMBER 23, 2022

In a recent study, racial minorities of an older age with non-classic cutaneous manifestations were more often to present with juvenile idiopathic inflammatory myopathies after COVID-19 infection.

196

196

Drug Topics

MAY 24, 2023

Data presented at Digestive Disease Week show that patients with IBD had less intense post-vaccination symptoms after a fourth dose.

Vaccines 187

Vaccines 187

Drug Topics

NOVEMBER 14, 2022

Hidradenitis suppurativa is a chronic inflammatory skin condition that presents with painful, deep, and inflamed lesions found in flexural, apocrine gland-bearing sites.

187

187

Drug Topics

OCTOBER 18, 2022

History of migraine may be associated with poor sleep in premenopausal and perimenopausal women, according to research presented at the North American Menopause Society Annual Meeting.

187

187

Drug Topics

NOVEMBER 14, 2022

Findings from research presented at the American College of Chest Physicians suggest the importance of selecting the right biologic from the start.

184

184

Drug Topics

APRIL 17, 2023

At the 44th National Association of Pediatric Nurse Practitioners Conference, a session presented data explaining why teenagers with T1D are at high risk for developing anorexia and bulimia.

185

185

Drug Topics

AUGUST 21, 2024

A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.

163

163

Pharmacy Times

NOVEMBER 7, 2022

A session presenter at the ASCP 2022 Annual Meeting addresses research investigating the value of preventative treatments when patients have a limited life expectancy.

181

181

PhRMA

NOVEMBER 8, 2022

Cancer event, hosting the session PhRMA Presents: The Future of Fighting Cancer. Our health care ecosystem has made tremendous progress in the fight against cancer, with the cancer death rate falling 32% from its peak in 1991. On November 3, PhRMA sponsored The Atlantic’s People v. PhRMA’s COO Lori Reilly, Esq.,

208

208

Drug Topics

JUNE 21, 2024

Four abstracts presented at ASCO 2024 delved into cannabis and pain management, potential medication interactions, and symptom mitigation, in patients with cancer.

162

162

Drug Topics

AUGUST 1, 2023

Mehrdad Hariri, RPh, CPh, MBA presented a session at July's Total Pharmacy Solution Summit on all the ways you can leverage those data for success. How many different ways can analytics assist your pharmacy? More than you may think.

187

187